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Abstract: Establish the role epigenetic methylation plays in the segregation of Medulloblastoma subgroups, through
pathway analysis in the literature and cancer genome Atlas publicly available data. The goal is to develop an in-vitro assay to
study therapeutic responses for subgroups 3 and 4. Functional analysis assays will be used to determine a mechanism for
chemoresistance in specific subgroups. In the current study, we assessed Medulloblastoma group 3 (D341) and Group 4 (D283)
cell lines using the DNA isolation kit and angiogenesis kits which allows for amplification via PCR and visualize tube
formation for tumor nutrients. Twist 1 fended were measured and recorded with the methylation Gold. Group 3 MB cell lines
treated with chemotherapy reagents demonstrate altered methylation profiles, angiogenic tube formation increase, a decrease in
apoptosis, and underwent phenotypic changes to overcome resistance. Gel electrophoresis results indicated consistent Twist-1
expression in the DAOY+cisplatin cell line in comparison to the control. Cells treated with chemotherapeutic agents evade the
mechanisms of apoptosis resulting in angiogenesis. We identified a possible correlation between cisplatin treatment, alteration
of methylation patterns, and an increase of Twist-1 gene expression. Twist-1 previously identified to be involved in
angiogenesis and cisplatin resistance (Roberts et al. 2016), this supports our hypothesis that alterations in methylation patterns
result in an increase in overall chemoresistance.
Keywords: Methylation, Angiogenesis, Chemo Resistant, Apoptosis

1. Introduction
Medulloblastoma (MB) is the most common malignant
brain tumor of childhood, and it accounts for about 20 percent
of all childhood brain tumors [23]. Survival rates in children
vary depending on the patient’s age and how much the tumor
spreads. Treatment options for this tumor consist of
neurosurgery, craniospinal radiation, and chemotherapy [10].
Unfortunately, many patients become resistant or are
intrinsically resistant to treatment [2]. Therefore, a better
understanding of the molecular biology of the tumor is
essential. There are four subtypes that have been identified in
children with medulloblastoma, WNT-activated, SHHactivated, Group 3 (non-WNT / non-SHH), and Group 4 (non-

WNT / non-SHH). The heterogeneous group 3 and group 4
MBs frequently have rare individual genetic alterations, but
have been shown to have altered epigenetic regulation, such as
distinct methylation profiles. Angiogenesis is feared in cancers
such as medulloblastoma. New blood vessels supplying the
tumor with blood, oxygen, and nutrients allows the tumor to
thrive as well as metastasize. We hypothesize that tumor cells
take advantage of alterations in methylation to become
resistant to treatment. Our results indicate that Group 3 MB
cell lines treated with chemotherapy reagents have altered
methylation profiles, avert apoptosis, and undergo phenotypic
changes to overcome resistance. Molecularly treatment options
are limited, and targeted therapies are still in preclinical
development [19]. Therefore, using multiple approaches to
attack these aggressive tumors are needed to improve survival
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rates DNA methylation is a biological process in which a
methyl group is added to a DNA molecule, changing the way
it reacts with other substances, such as transcription factors
[16]. DNA methylation also plays a role in gene expression;
usually turning genes “off” when the DNA is methylated at
those genes [5]. In cancer, such as medulloblastoma, the tumor
suppressor genes are most often methylated, or even
hypermethylated, which leads to them being turned off. This
allows tumors to grow and spread and start forming new blood
vessels to supply the tumor with vital nutrients [13].
We focused on the two main subgroups which are group 3
and group 4 [4]. The other two are WNT and SHH, however
little is known about the signaling pathways of these two
subgroups. WNT is a single transduction signaling pathway
that begins with proteins. These proteins pass signals into
cells through the surface to the receptors to relay a message.
WNT is the least common out of the four subgroups and has
the most favorable prognosis [6].
SHH helps in cerebral development in which it induces
proliferation of precursor cells in the developing tissues.
SHH is normally secreted by the purkinje neurons and the
tumors are found to arise from the granule neuron precursor
cells. Research has shown that there is an overlap in the
WNT and SHH signaling pathways making this the second
best subgroup for a promising prognosis [24].
Group 3 and Group 4 both have a devastating prognosis
and are the most common of the four. Due to the high
mortality rates of these subgroups, chemosensitivity is at its
highest. Group 3 subgroups are MYC amplified. MYC is a
master regulator in the sense that it can transcriptionally
activate and repress specific target genes. Group 4 subgroups
have a large cell anaplastic histology [24].
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methylation acts as an epigenetic mechanism used by cells to
control gene expression and is essential to understand the
roles of DNA methylation in regulating how to develop
different cell types [5]. A number of mechanisms exist to
control gene expression in eukaryotes, but DNA methylation
is a commonly used epigenetic signaling tool that can fix
genes in the “off” position or silencing of the genes. The
MethylFlash™ Global DNA Methylation Kit (Zymo
Epigentek HTB-185) is a complete set of optimized buffers
and reagents to colorimetrically quantify global DNA
methylation status by specifically measuring levels of 5methylcytosine (5-mC) in a simplified, "one step” reaction.
The kit contains all reagents necessary for the quantification
of global DNA methylation. In this assay, DNA is bound to
strip-wells that are specifically treated to have a high DNA
affinity. This allows global DNA methylation to be directly
measured more quickly than other techniques [11].
2.2. Caspase 3 Assay Kit
The Caspase 3 assay kit (Thermo-Fisher) provides a
simple and convenient means for assaying the activity of
caspases that recognize the sequence DEVD. The assay is
based on spectrophotometric detection of the chromophore pnitroaniline (p-NA) after cleavage from the labeled substrate
DEVD-pNA. The p-NA light emission can be quantified
using a spectrophotometer or microtiter plate reader at 400 or
405 nm. Comparison of the absorbance of p-NA from an
apoptotic sample with an uninduced control allows
determination of the fold increase in caspase 3 activity. An
increase in absorbance reflects increased caspase 3 activity,
indicating more induced apoptosis.
2.3. MitoRed Assay

2. Materials and Methods
2.1. Cell Lines and DNA Methylation Analysis
Human medulloblastoma cells were obtained from
American Type Culture Collection, ATCC (61381; Manassas,
VA, USA) [4, 3]. Cells were grown in the presence of 10 mM
glutamine as a supplement in the growth media to render
them resistant to chemotherapy. Cells were grown and
maintained under humidity at 37°C, 5% CO2, and were used
for experiments between passages three and six. Confluent
cells were harvested using 0.05% Trypsin-EDTA from
Invitrogen (25300-062, Carlsbad, CA). Cells were then
collected by centrifugation at 4°C for 7 min (180 X G/1000
rpm) and were counted using trypan blue dye (Invitrogen) on
a hemocytometer. To ensure reproducibility, all experiments
were carried out in triplicate.
DNA methylation is a very important functional epigenetic
modification of mammalian DNA, which has been implicated
in embryonic development, chromosomal stability,
transcription, X-chromosome inactivation and complex
diseases such as cancers [18]. DNA methylation enables cells
to control gene expression in a cell type-specific manner,
which further leads to different phenotypes. DNA

MitoRed (needs catalog #) is a membrane permeable
Rhodamine based dye. This dye localizes in the mitochondria
and emits red fluorescence. The interaction of MitoRed with
the mitochondria depends on the membrane potential of the
mitochondria. The mitochondria can be stained with 20 to 200
nm of MitoRed. The excitation and emission wavelengths of
MitoRed are 560 nm and 580 nm, respectively. This dye only
stains mitochondria in live cells, therefore, increased
absorbance equates to increased live cells.
2.3.1. Trypan Blue Exclusion Assay
One of the earliest and most common methods for
measuring cell viability is the trypan blue staining assay.
Trypan blue is an azo dye that is cell membrane impermeable
and therefore only enters cells with compromised membranes.
Upon entry into the cell, trypan blue binds to intracellular
proteins thereby rendering the cells a blue color. The trypan
blue staining assay allows for a direct identification and
enumeration of live (unstained) and dead (blue) cells in a
given population. In this assay, a cell suspension is simply
mixed with trypan blue and then visually examined to
determine whether cells take up or exclude the dye. In the
protocol presented here, a viable cell will have a clear
cytoplasm whereas a nonviable cell will have a blue
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cytoplasm.
2.3.2. DNA Isolation
DNA was extracted from cellular components according to
protocol established in QIAamp DNA mini kit from Qiagen.
Concentration verified via the ThermoFisher 2000/2000c
nanodrop.
2.3.3 Amplification Via PCR
Polymerase Chain Reaction utilized to rapidly duplicate
genes via temperature manipulation of hydrogen bonds, RNA
primers, and Taq polymerase (New England Biolabs). Samples
were prepared in New England Biolabs Master Mix Taq.
Primers were optimized for melting temperatures, and PCR
was run following the standard conditions: initial denaturation
at 95°C for thirty seconds, followed by 30 cycles of 95°C for
thirty seconds, 50°C for 30 seconds, and 64°C for one minute.
Samples were kept at 4°C until run on the agarose gel. Primer
sequences
are
as
follows:
Caspase
3,
5′TGACTGGAAAGCCGAAACTC
3′
and
5′AGCCTCCACCGGTATCTTCT-3′;
Caspase
8,
5′CCGAGCTGGACT
TGTGACC
-3′
and
5′CTGCCCAGTTCTTCAGCAAT-3′,
5’-GACAAGAATCCGACCAAATGGCAAA-3’ and 5’-AAAAGGATCCATGAGAAATCCTTGTGG-3’
for
BIM,
5′GGCTCAGCTACGCCTTCTC-3′
and
5′TCCTTCTCTGGAAACAATGACA-3′ for TWIST-1, HPRT,
5′
CTTCCTCCTCAGACCGCTTT
-3′
and
5′TTTCCAAATCCTCGGCATAA3′
for
HPRT,
5’CTCTTCTGCCTGCTGCACTTTG-3’
and
5’ATGGGCTACAGGCTTGTCACTC3’ for TNFa, 5’-AGA
GTC TAT AGG CCC ACC CC-3’ and 5’-GCT CGA CGC
TAG
GAT
CTG
AC-3’P53,
5’CCAAGGAGATCGACCTGGTCAA3’
and
5’GCCGTCAAAACTGTGTGTCCCT-3’ for CAV1, and 5’GCTTTGTGTCGCTCTTCCGCAT-3’
and
5’TACAGCACGCTGAAGACGCCAA-3’ for FZD1. All PCR
reactions were performed on CFX-96 Bio-Rad RT System in
triplicate and validated by the presence of a single band [21].

instructions. Cells from each condition were added in
triplicate in a 96-well sterile plate and were incubated at 37ºC
for about 18 hours. The growth medium was gently removed,
and formed tubular structures were fluorescently labelled
with Calcein AM. A Zeiss Axiovert 200 M inverted
fluorescent microscope and Axio Vision software 4.6 were
used to examine the formed tubes. Obtained images were
processed and analyzed using Angiogenesis Analyzer, an
ImageJ application. Averaged numbers of branches from at
least three images per well from three wells per condition
were computed [12].

3. Results
Global Increase Methylation status in Medulloblastoma
Methylation has the ability to change the activity of DNA
segments without changing the actual sequence. This is
accomplished by the methylation of histone bodies, which
results in the formation of heterochromatin from euchromatin,
inactivating a specific gene or several genes. This is a key
factor when it comes to Medulloblastoma because
hypermethylation and hypomethylation can provide a
significant amount of information regarding prognosis. Given
that chemoresistance is a major challenge of all cancers, if
we can alter the epigenetics it is our hope to induce a therapy
response. As represented in Figure 1, there is a slight increase
in the amount of methylation present in DAOY DNA as a
result of cisplatin treatment. This suggests that cisplatin
treatment results in the alteration of the methylation patterns
of the cancer cell DNA. This would allow for the
deactivation of certain genes, and the activation of others.
Future work will cover results for D348+Cisplatin,
D283+Cisplatin, anol+Cisplatin.

2.3.4. Gel Electrophoresis
Separation of DNA strands by size via application of an
electrical current through an agarose gel. This is utilized to
provide a qualitative analysis of gene expression. DNA
samples were stained with ethidium bromide and run on a
0.7% agarose gel at 100 volts for 35-50 minutes. PCR
products were visualized using the UV-light camera and
imaged for qualitative analysis.
2.3.5. Endothelial Tube Forming Assay (in Vitro
Angiogenesis)
The in vitro angiogenesis assay kit tests a cell's ability to
form tubes indicating pro-angiogenesis. This assay was used
to examine cellular phenotype and formation of capillary
precursor structures in our cell lines. Control and treated cells
(3 x 104) were added onto endothelial cell matrix (ECM) gel
obtained from Cell Biolabs (San Diego, CA, USA). The
assay was carried out according to the manufacturer’s

Figure 1. Methylation Pattern Analysis: There is a significant difference
between control and DAOY+cisplatin methylation patterns. However, there
was no significant difference in global methylation detected among the
experimental values.
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3.1. Apoptosis and Chemo-resistivity
Apoptosis, otherwise known as programmed cell death, is
a growth-limiting regulatory mechanism by which cells can
trigger their own death in response to extracellular signals
because of irreparable cellular or DNA damage [1]. The
process of programmed cell death is especially important in
the treatment of cancers, such as Medulloblastoma because
chemotherapy is generally the first line of treatment used to
induce apoptosis in cancer cells. As shown in Figures 2-5, the
MB cell lines are averting the mechanisms of apoptosis
despite their treatment with chemotherapeutic compounds in
comparison to the control cells. This suggests that the MB
cancer cell lines are chemoresistant [22].

Figure 2. Trypan blue is a dye that only stains cells that are not viable
because it cannot cross the plasma membrane in viable cells. The control,
DAOY and D348 cells were all treated with chemotherapeutic agents. After
assay, the control cells had a significantly higher amount of cells that were
stained blue, this indicates they are undergoing apoptosis while the MB cells
lines are evading apoptosis.

Viable cells have cell membranes that are intact. The cell
membrane excludes certain types of dyes such as trypan blue
from getting into the cell. Cells that do not exclude trypan
blue dye, are not viable and therefore, are in an apoptotic
state. We treated the control, and cell lines DAOY and D341
with chemotherapeutic compounds. The percentages of the
cells that stained blue were much higher for the control group
than that of the cell lines. This directly indicates that the
control cells are undergoing apoptosis and the cell lines are
evading the mechanisms of apoptosis although they were
treated with chemotherapeutic drugs.

Figure 3. The activity of caspases are detected based upon the
spectrophotometric detection of the chromophore p-nitroaniline (p-NA) after
cleavage from the labeled substrate DEVD-pNA. After chemotherapeutic
based treatment, the average absorbance of p-NA light emission was highest
for the control. This demonstrates that the MB cell lines are able to avoid the
mechanisms of caspases that work to induce apoptosis in cells.

Figure 4. Mito Red is a rhodamine based dye that only stains mitochondria
in live cells and emits red fluorescence at an absorbance of 594 nm. After
chemotherapeutic treatment the cell lines D283, D341 and DAOY had
significantly higher amounts of absorption compared to the control
indicating they are averting apoptosis despite chemotherapeutic treatment.

As seen in figure 3, the activity of caspases that recognize
the sequence DEVD was able to be determined using the
Caspase 3 assay kit. The activity of caspases are detected
based upon the spectrophotometric detection of the
chromophore p-nitroaniline (p-NA) after cleavage from the
labeled substrate DEVD-pNA. After chemotherapy based
treatment, the average absorbance of p-NA light emission
was recorded for the control and the cell lines DAOY and
D348. The control cells have the highest amount of
absorption, which reflects increased Caspase 3 activity,
indicating more induced apoptosis within the cells. Both cell
lines treated with chemotherapeutic compounds had a
significantly less amount of absorption. This indicated that
these cell lines are able to avoid the mechanisms of Caspase
3 that work to induce apoptosis in cells [20].

Figure 5. Quick and easy two-color assay to determine viability of cells in a
population based on plasma membrane integrity and esterase activity. Live
cells are distinguished by the presence of ubiquitous intracellular esterase
activity, determined by the enzymatic conversion of the virtually
nonfluorescent cell-permeant calcein AM to the intensely fluorescent calcein.
The polyanionic dye calcein is well retained within live cells, producing an
intense uniform green fluorescence in live cells.

Figure 4 Mito Red is a cell membrane permeable
Rhodamine-based dye. This dye localizes within mitochondria
and emits red fluorescence. The interaction of Mito Red within
the mitochondria of the cell is dependent upon the membrane
potential of the mitochondria. This dye only stains
mitochondria in live cells, therefore an increased absorbance
equates to an increased amount of live cells. At an absorbance
of 594 nm, the control cells that were treated with
chemotherapy drugs had a decreased level of absorption.
However, when the cell lines D283, D341 and DAOY were
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treated, the absorbance was much higher than those of the
treated control cells. Each of the results on treatments of the
cell lines affirmed that cancer cells are evading apoptosis, even
when treated with chemotherapeutic compounds.
3.2. Angiogenesis with the Use of Cisplatin

Figure 6. This chart measures tube formation in comparison to the number
of days with the use of cisplatin. DAOY NT were used as a control which
showed no significant change at Day 10 in tube formation. DAOY cells were
treated with cisplatin and presented with a large increase in tube formation.

The formation of new blood cells, angiogenesis, is a way
that the body supplies the tumor with an adequate amount of
nutrients to allow the cell to survive [7]. We used DAOY
cells that were treated with cisplatin as well as our control,
DAOY NT (no treatment). As seen in figure 3a and 3b,
angiogenesis increases with the use of cisplatin. As seen over
a 10 day period, angiogenic responses increase in the DAOY
cell treated with cisplatin, as days continue. This is most
likely a result of the tumor trying to survive, by increasing
the amount of nutrients to the tumor [17].
Tube formation is a response to the cisplatin. As seen in
figure 6, tube formation increases with the use of cisplatin.
This auto response is for tumor growth and survival DAOY
+cis DAOY NT.

Figure 7. Is showing DAOY with the addition of cisplatin to the left and to
the right are the DAOY cells without treatment. Tube formation is presented
in the DAOY+ Cis in response to the chemotherapy.

4. Discussion
There was no significant correlation between the
experimental methylation values as we had hypothesized.
However, this does not necessarily indicate constant
methylation patterns. It is entirely possible that the overall
net amount of heterochromatin remained the same, but equal

amounts of methylation and acetylation occurred in different
locations. Thus, it is still possible that alterations in
methylation patterns have occurred. In order to verify this,
future research should include additional methylation testing
for reliability.
Apoptosis, or programmed cell death, is a growthlimiting regulatory mechanism by which cells can trigger
their own death in response to extracellular signals because
of irreparable cellular or DNA damage [1]. The ability of
tumor cells to elude apoptosis is a hallmark of most types of
cancer.
Utilizing the amplified DNA segments generated via PCR,
our gel electrophoresis results clearly indicate a difference in
the gene expression between our control and DAOY cell
lines. In figure 3, p53 and BIM are clearly expressed in our
untreated control cell line, as expected in a healthy cell. Both
genes are vital in certain apoptotic pathways ensuring the
death of a cell too damaged to safely reproduce (NIH,
2019)(Gogda et al. 2013). However, both experimental cell
lines DAOY and DAOY+Cisplatin, lack p53 and BIM.
Instead, they both express CAV1. This gene is responsible
for the production of an integral protein and is commonly
found to be overexpressed in metastatic drug-resistant tumors
and cancer cell lines (Shatz and Liscovitch, 2008). These
findings support the claim that cancer cells and somatic cells
display different epigenetic properties.
Furthermore, cisplatin treatment resulted in clear
differences in the gene expression within the same cell lines.
With respect to our control, there is a loss of BIM expression,
in conjunction with increased expression of TNFAI, CASP3,
and HPRT. The loss of BIM upon treatment of the control
cells was unexpected, as BIM activity has been correlated
with neuron apoptosis (BCL2L11 Gene 2020). However,
further evidence also suggests that BIM has anti-apoptotic
capabilities (Gogada et al. 2013). Therefore, it is possible that
BIM was repressed as an anti-apoptotic response, but this
requires further investigation. TNFA1 manages a significant
amount of processes, including cell proliferation,
differentiation, apoptosis through cytokine signalling, thus
making it an excellent candidate for observation. CASP3 is
responsible for the production of the “executioner” caspase 3
protein, which plays a key role in apoptosis through protein
catabolism (Walsh et al. 2008). Finally, HPRT was
designated as our negative control, as it’s protein product is
involved in purine formation, not cell survival or
proliferation (HPRT-1 Gene 2020). However, it is possible
that there is some novel interaction with cisplatin that we
were not anticipating.
When the DAOY cell line was treated with cisplatin,
CAV1 remained expressed, while Twist-1 also became
expressed. Given the role of Twist-1 in cisplatin resistance
and angiogenesis (Roberts et al. 2016), the increased
expression of this gene following cisplatin treatment is
noteworthy. Our hypothesis is partially confirmed in that our
data shows tumor cells are experiencing alterations in gene
expression in response to cisplatin to improve
chemoresistance through increased cell survivability and
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angiogenesis. A slight change in methylation patterns are
demonstrated between DAOY and DAOY+Cpt, but it is not
significant. However, it is entirely possible that certain genes
were methylated and others were acetylated, resulting in no
significant net change in methylation pattern, but still
allowing for new genes to be expressed. As stated earlier,
additional tests are needed to determine if methylation is
responsible for the change in gene expression. Analysis of
experimental cell lines D283, D341 (subgroups 3 and 4) are
currently pending at this time. In the future, we seek to verify
the observed differences in gene expression through
repetition of the DNA isolation, PCR and gel electrophoresis
procedures.
As part of a survival mechanism, it is demonstrated that
DAOY cells treated with cisplatin result in altered
hypervascularization phenotype, consistent with angiogenesis,
compared to their chemo sensitive counterparts. These results
suggest that angiogenesis is a possible mechanism of
chemoresistance in MB through the development of a
capillary support network which is vital for cancer cells
because these blood vessels supply tumor cells with the
nutrients for growth. The endothelial tube formation allows a
network or capillaries to form within and surrounding the
tumor for an adequate supply of blood to the tumor [8].
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